BCL2 and malignant colon neoplasm: Chen’s group (Chen et al., 2016) has found that Lnc_ASNR promotes the reduction of cytoplasmic AUF1 levels and inhibits AUF1-mediated degradation of Bcl-2 mRNA in colon cancer RKO cells, which leads to high expression of Bcl-2 and significantly inhibits cell apoptosis.